{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:31:38Z","timestamp":1788539498212,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL158054"],"award-info":[{"award-number":["HL158054"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL160470"],"award-info":[{"award-number":["HL160470"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL166214"],"award-info":[{"award-number":["HL166214"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL176955"],"award-info":[{"award-number":["HL176955"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-72276-0","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T01:06:47Z","timestamp":1776992807000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["MicroRNA-30c analog C2 decreases plasma cholesterol and atherosclerosis without causing liver injury in preclinical studies"],"prefix":"10.1038","volume":"17","author":[{"given":"Binu","family":"Prakash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujith","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9139-0468","authenticated-orcid":false,"given":"Shannon R.","family":"Scarberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhargavi","family":"Gangula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Musa","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandana","family":"Prakashmurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Valmiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otabek","family":"Pulatov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep Kumar","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Carsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9599-804X","authenticated-orcid":false,"given":"Ryan E.","family":"Temel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6198-390X","authenticated-orcid":false,"given":"Jia","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9663-300X","authenticated-orcid":false,"given":"M. Mahmood","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"72276_CR1","doi-asserted-by":"publisher","first-page":"117359","DOI":"10.1016\/j.cca.2023.117359","volume":"545","author":"M Huang","year":"2023","unstructured":"Huang, M., Zheng, J., Chen, L., You, S. & Huang, H. Role of apolipoproteins in the pathogenesis of obesity. Clin. Chim. Acta 545, 117359 (2023).","journal-title":"Clin. Chim. Acta"},{"key":"72276_CR2","doi-asserted-by":"crossref","unstructured":"Cole, J., Zubiran, R., Wolska, A., Jialal, I., & Remaley, A. T. Use of apolipoprotein B in the era of precision medicine: time for a paradigm change? J. Clin. Med. 12, 5737 (2023).","DOI":"10.3390\/jcm12175737"},{"key":"72276_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1056\/NEJMe048326","volume":"352","author":"MR Ehrenstein","year":"2005","unstructured":"Ehrenstein, M. R., Jury, E. C. & Mauri, C. Statins for atherosclerosis: as good as it gets? N. Engl. J. Med. 352, 73\u201375 (2005).","journal-title":"N. Engl. J. Med."},{"key":"72276_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0503-4","volume":"13","author":"RM Stoekenbroek","year":"2015","unstructured":"Stoekenbroek, R. M., Kastelein, J. J. & Huijgen, R. PCSK9 inhibition: the way forward in the treatment of dyslipidemia. BMC Med. 13, 258 (2015).","journal-title":"BMC Med."},{"key":"72276_CR5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.tcm.2019.09.005","volume":"30","author":"MD Ritchey","year":"2020","unstructured":"Ritchey, M. D., Wall, H. K., George, M. G. & Wright, J. S. US trends in premature heart disease mortality over the past 50 years: where do we go from here? Trends Cardiovasc. Med. 30, 364\u2013374 (2020).","journal-title":"Trends Cardiovasc. Med."},{"key":"72276_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1161\/CIRCGENETICS.108.795013","volume":"1","author":"D Voora","year":"2008","unstructured":"Voora, D. et al. Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose response. Circ. Cardiovasc. Genet. 1, 100\u2013106 (2008).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"72276_CR7","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.amjcard.2014.02.033","volume":"113","author":"Z Ahmad","year":"2014","unstructured":"Ahmad, Z. Statin intolerance. Am. J. Cardiol. 113, 1765\u20131771 (2014).","journal-title":"Am. J. Cardiol."},{"key":"72276_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.pcad.2016.07.009","volume":"59","author":"DR Saxon","year":"2016","unstructured":"Saxon, D. R. & Eckel, R. H. Statin intolerance: a literature review and management strategies. Prog. Cardiovasc. Dis. 59, 153\u2013164 (2016).","journal-title":"Prog. Cardiovasc. Dis."},{"key":"72276_CR9","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1161\/CIRCULATIONAHA.113.001292","volume":"129","author":"DJ Rader","year":"2014","unstructured":"Rader, D. J. & Kastelein, J. J. Lomitapide and mipomersen: two first-in-class drugs for reducing low-density lipoprotein cholesterol in patients with homozygous familial hypercholesterolemia. Circulation 129, 1022\u20131032 (2014).","journal-title":"Circulation"},{"key":"72276_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0140-6736(14)61399-4","volume":"385","author":"FJ Raal","year":"2015","unstructured":"Raal, F. J. et al. PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial. Lancet 385, 331\u2013340 (2015).","journal-title":"Lancet"},{"key":"72276_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1194\/jlr.R200014-JLR200","volume":"44","author":"MM Hussain","year":"2003","unstructured":"Hussain, M. M., Shi, J. & Dreizen, P. Microsomal triglyceride transfer protein and its role in apolipoprotein B-lipoprotein assembly. J. Lipid Res. 44, 22\u201332 (2003).","journal-title":"J. Lipid Res."},{"key":"72276_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1743-7075-9-14","volume":"9","author":"MM Hussain","year":"2012","unstructured":"Hussain, M. M., Rava, P., Walsh, M., Rana, M. & Iqbal, J. Multiple functions of microsomal triglyceride transfer protein. Nutr. Metab. 9, 14 (2012).","journal-title":"Nutr. Metab."},{"key":"72276_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/10408363.2016.1221883","volume":"54","author":"MT Walsh","year":"2017","unstructured":"Walsh, M. T. & Hussain, M. M. Targeting microsomal triglyceride transfer protein and lipoprotein assembly to treat homozygous familial hypercholesterolemia. Crit. Rev. Clin. Lab Sci. 54, 26\u201348 (2017).","journal-title":"Crit. Rev. Clin. Lab Sci."},{"key":"72276_CR14","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1194\/jlr.R083451","volume":"59","author":"A Sirwi","year":"2018","unstructured":"Sirwi, A. & Hussain, M. M. Lipid transfer proteins in the assembly of apoB-containing lipoproteins. J. Lipid Res. 59, 1094\u20131102 (2018).","journal-title":"J. Lipid Res."},{"key":"72276_CR15","doi-asserted-by":"publisher","first-page":"17377","DOI":"10.1074\/jbc.R100068200","volume":"277","author":"EA Fisher","year":"2002","unstructured":"Fisher, E. A. & Ginsberg, H. N. Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins. J. Biol. Chem. 277, 17377\u201317380 (2002).","journal-title":"J. Biol. Chem."},{"key":"72276_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1146\/annurev.nutr.20.1.169","volume":"20","author":"NO Davidson","year":"2000","unstructured":"Davidson, N. O. & Shelness, G. S. APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation. Annu Rev. Nutr. 20, 169\u2013193 (2000).","journal-title":"Annu Rev. Nutr."},{"key":"72276_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature04688","volume":"441","author":"TS Zimmermann","year":"2006","unstructured":"Zimmermann, T. S. et al. RNAi-mediated gene silencing in non-human primates. Nature 441, 111\u2013114 (2006).","journal-title":"Nature"},{"key":"72276_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/CRD.0b013e31823424be","volume":"20","author":"DN Ricotta","year":"2012","unstructured":"Ricotta, D. N. & Frishman, W. Mipomersen: a safe and effective antisense therapy adjunct to statins in patients with hypercholesterolemia. Cardiol. Rev. 20, 90\u201395 (2012).","journal-title":"Cardiol. Rev."},{"key":"72276_CR19","doi-asserted-by":"publisher","first-page":"943","DOI":"10.2174\/138161211795428768","volume":"17","author":"M Rizzo","year":"2011","unstructured":"Rizzo, M. & Wierzbicki, A. S. New lipid modulating drugs: the role of microsomal transport protein inhibitors. Curr. Pharm. Des. 17, 943\u2013949 (2011).","journal-title":"Curr. Pharm. Des."},{"key":"72276_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0140-6736(12)61731-0","volume":"381","author":"M Cuchel","year":"2013","unstructured":"Cuchel, M. et al. Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study. Lancet 381, 40\u201346 (2013).","journal-title":"Lancet"},{"key":"72276_CR21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/MOL.0b013e32836139df","volume":"24","author":"M Cuchel","year":"2013","unstructured":"Cuchel, M. & Rader, D. J. Microsomal transfer protein inhibition in humans. Curr. Opin. Lipido 24, 246\u2013250 (2013).","journal-title":"Curr. Opin. Lipido"},{"key":"72276_CR22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1056\/NEJMoa061189","volume":"356","author":"M Cuchel","year":"2007","unstructured":"Cuchel, M. et al. Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia. N. Engl. J. Med. 356, 148\u2013156 (2007).","journal-title":"N. Engl. J. Med."},{"key":"72276_CR23","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/MOL.0b013e328312707c","volume":"19","author":"MM Hussain","year":"2008","unstructured":"Hussain, M. M. & Bakillah, A. New approaches to target microsomal triglyceride transfer protein. Curr. Opin. Lipido 19, 572\u2013578 (2008).","journal-title":"Curr. Opin. Lipido"},{"key":"72276_CR24","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/ncpcardio1250","volume":"5","author":"FF Samaha","year":"2008","unstructured":"Samaha, F. F., McKenney, J., Bloedon, L. T., Sasiela, W. J. & Rader, D. J. Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia. Nat. Clin. Pract. Cardiovasc. Med. 5, 497\u2013505 (2008).","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"72276_CR25","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/ncpcardio1251","volume":"5","author":"TR Joy","year":"2008","unstructured":"Joy, T. R. & Hegele, R. A. Microsomal triglyceride transfer protein inhibition: friend or foe? Nat. Clin. Pract. Cardiovasc. Med. 5, 506\u2013508 (2008).","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"72276_CR26","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1101\/gad.1399806","volume":"20","author":"MA Valencia-Sanchez","year":"2006","unstructured":"Valencia-Sanchez, M. A., Liu, J., Hannon, G. J. & Parker, R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 20, 515\u2013524 (2006).","journal-title":"Genes Dev."},{"key":"72276_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215\u2013233 (2009).","journal-title":"Cell"},{"key":"72276_CR28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrg2843","volume":"11","author":"J Krol","year":"2010","unstructured":"Krol, J., Loedige, I. & Filipowicz, W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 11, 597\u2013610 (2010).","journal-title":"Nat. Rev. Genet."},{"key":"72276_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/MOL.0000000000000162","volume":"26","author":"S Irani","year":"2015","unstructured":"Irani, S. & Hussain, M. M. Role of microRNA-30c in lipid metabolism, adipogenesis, cardiac remodeling and cancer. Curr. Opin. Lipido 26, 139\u2013146 (2015).","journal-title":"Curr. Opin. Lipido"},{"key":"72276_CR30","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/nm.3200","volume":"19","author":"J Soh","year":"2013","unstructured":"Soh, J., Iqbal, J., Queiroz, J., Fernandez-Hernando, C. & Hussain, M. M. MicroRNA-30c reduces hyperlipidemia and atherosclesrosis by decreasing lipid synthesis and lipoprotein secretion. Nat. Med. 19, 892\u2013900 (2013).","journal-title":"Nat. Med."},{"key":"72276_CR31","doi-asserted-by":"publisher","first-page":"18397","DOI":"10.1074\/jbc.M116.728451","volume":"291","author":"S Irani","year":"2016","unstructured":"Irani, S. et al. MicroRNA-30c mimic mitigates hypercholesterolemia and atherosclerosis in mice. J. Biol. Chem. 291, 18397\u201318409 (2016).","journal-title":"J. Biol. Chem."},{"key":"72276_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101813","volume":"298","author":"PK Yadav","year":"2022","unstructured":"Yadav, P. K. et al. Novel efficacious microRNA-30c analogs reduce apolipoprotein B secretion in human hepatoma and primary hepatocyte cells. J. Biol. Chem. 298, 101813 (2022).","journal-title":"J. Biol. Chem."},{"key":"72276_CR33","first-page":"e1082","volume":"139","author":"SM Grundy","year":"2019","unstructured":"Grundy, S. M. et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 139, e1082\u2013e1143 (2019).","journal-title":"Circulation"},{"key":"72276_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.atherosclerosis.2019.05.009","volume":"286","author":"AC Burke","year":"2019","unstructured":"Burke, A. C. et al. Naringenin enhances the regression of atherosclerosis induced by a chow diet in Ldlr(-\/-) mice. Atherosclerosis 286, 60\u201370 (2019).","journal-title":"Atherosclerosis"},{"key":"72276_CR35","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1172\/JCI57275","volume":"121","author":"KJ Rayner","year":"2011","unstructured":"Rayner, K. J. et al. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J. Clin. Investig. 121, 2921\u20132931 (2011).","journal-title":"J. Clin. Investig."},{"key":"72276_CR36","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.ajpath.2011.05.020","volume":"179","author":"Y Zhao","year":"2011","unstructured":"Zhao, Y. et al. Stage-specific remodeling of atherosclerotic lesions upon cholesterol lowering in LDL receptor knockout mice. Am. J. Pathol. 179, 1522\u20131532 (2011).","journal-title":"Am. J. Pathol."},{"key":"72276_CR37","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/nbt1326","volume":"25","author":"H Azuma","year":"2007","unstructured":"Azuma, H. et al. Robust expansion of human hepatocytes in Fah-\/-\/Rag2-\/-\/Il2rg-\/- mice. Nat. Biotechnol. 25, 903\u2013910 (2007).","journal-title":"Nat. Biotechnol."},{"key":"72276_CR38","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/j.1476-5381.2009.00267.x","volume":"157","author":"V Sharma","year":"2009","unstructured":"Sharma, V. & McNeill, J. H. To scale or not to scale: the principles of dose extrapolation. Br. J. Pharmacol. 157, 907\u2013921 (2009).","journal-title":"Br. J. Pharmacol."},{"key":"72276_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair, A. B. & Jacob, S. A simple practice guide for dose conversion between animals and human. J. Basic Clin. Pharm. 7, 27\u201331 (2016).","journal-title":"J. Basic Clin. Pharm."},{"key":"72276_CR40","doi-asserted-by":"crossref","unstructured":"Meng, Z. et al. The atypical antipsychotic quetiapine induces hyperlipidemia by activating intestinal PXR signaling. JCI Insight 4, e125657 (2019).","DOI":"10.1172\/jci.insight.125657"},{"key":"72276_CR41","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1161\/01.ATV.4.4.418","volume":"4","author":"K Yamamoto","year":"1984","unstructured":"Yamamoto, K., Shen, B., Zarins, C. & Scanu, A. M. In vitro and in vivo interactions of Triton 1339 with plasma lipoproteins of normolipidemic rhesus monkeys. Preferential effects on high-density lipoproteins. Arteriosclerosis 4, 418\u2013434 (1984).","journal-title":"Arteriosclerosis"},{"key":"72276_CR42","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/jn\/104.2.223","volume":"104","author":"RH Fiser Jr","year":"1974","unstructured":"Fiser, R. H. Jr, Denniston, J. C., Rindsig, R. B. & Beisel, W. R. Triglyceride secretion rates: use of Triton WR 1339 in the rhesus monkey. J. Nutr. 104, 223\u2013226 (1974).","journal-title":"J. Nutr."},{"key":"72276_CR43","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/jn\/111.4.733","volume":"111","author":"OW Portman","year":"1981","unstructured":"Portman, O. W., Alexander, M., Neuringer, M., Illingworth, D. R. & Alam, S. S. Effects of long-term protein deficiency on plasma lipoprotein concentrations and metabolism in rhesus monkeys. J. Nutr. 111, 733\u2013745 (1981).","journal-title":"J. Nutr."},{"key":"72276_CR44","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/0005-2760(77)90097-2","volume":"486","author":"OW Portman","year":"1977","unstructured":"Portman, O. W., Alexander, M., Tanaka, N. & Illingworth, D. R. Triacylglycerol and very low density lipoprotein secretion into plasma of squirrel monkeys. Biochim. Biophys. Acta 486, 470\u2013482 (1977).","journal-title":"Biochim. Biophys. Acta"},{"key":"72276_CR45","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1194\/jlr.D500019-JLR200","volume":"46","author":"JS Millar","year":"2005","unstructured":"Millar, J. S., Cromley, D. A., McCoy, M. G., Rader, D. J. & Billheimer, J. T. Determining hepatic triglyceride production in mice: comparison of poloxamer 407 with Triton WR-1339. J. Lipid Res. 46, 2023\u20132028 (2005).","journal-title":"J. Lipid Res."},{"key":"72276_CR46","doi-asserted-by":"publisher","first-page":"14372","DOI":"10.1074\/jbc.M113.459602","volume":"288","author":"J Josekutty","year":"2013","unstructured":"Josekutty, J., Iqbal, J., Iwawaki, T., Kohno, K. & Hussain, M. M. Microsomal triglyceride transfer protein inhibition induces endoplasmic reticulum stress and increases gene transcription via Ire1\u03b1\/cJun to enhance plasma ALT\/AST. J. Biol. Chem. 288, 14372\u201314383 (2013).","journal-title":"J. Biol. Chem."},{"key":"72276_CR47","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/hep.25504","volume":"55","author":"I Khatun","year":"2012","unstructured":"Khatun, I. et al. Phospholipid transfer activity of MTP promotes assembly of phospholipid-rich apoB-containing lipoproteins and reduces plasma as well as hepatic lipids in mice. Hepatology 55, 1356\u20131368 (2012).","journal-title":"Hepatology"},{"key":"72276_CR48","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/B978-0-12-416618-9.00020-0","volume":"542","author":"FK Huynh","year":"2014","unstructured":"Huynh, F. K., Green, M. F., Koves, T. R. & Hirschey, M. D. Measurement of fatty acid oxidation rates in animal tissues and cell lines. Methods Enzymol. 542, 391\u2013405 (2014).","journal-title":"Methods Enzymol."},{"key":"72276_CR49","doi-asserted-by":"publisher","first-page":"100257","DOI":"10.1016\/j.jlr.2022.100257","volume":"63","author":"N Anaganti","year":"2022","unstructured":"Anaganti, N., Chattopadhyay, A., Poirier, J. T. & Hussain, M. M. Generation of hepatoma cell lines deficient in microsomal triglyceride transfer protein. J. Lipid Res. 63, 100257 (2022).","journal-title":"J. Lipid Res."},{"key":"72276_CR50","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1194\/jlr.R054114","volume":"56","author":"PA Dawson","year":"2015","unstructured":"Dawson, P. A. & Karpen, S. J. Intestinal transport and metabolism of bile acids. J. Lipid Res. 56, 1085\u20131099 (2015).","journal-title":"J. Lipid Res."},{"key":"72276_CR51","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-nutr-082018-124344","volume":"39","author":"JYL Chiang","year":"2019","unstructured":"Chiang, J. Y. L. & Ferrell, J. M. Bile acids as metabolic regulators and nutrient sensors. Annu Rev. Nutr. 39, 175\u2013200 (2019).","journal-title":"Annu Rev. Nutr."},{"key":"72276_CR52","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1053\/j.gastro.2020.11.040","volume":"160","author":"C Bredefeld","year":"2021","unstructured":"Bredefeld, C., Peretti, N., Hussain, M. M. & Medical Advisory, P. New Classification and Management of Abetalipoproteinemia and Related Disorders. Gastroenterology 160, 1912\u20131916 (2021).","journal-title":"Gastroenterology"},{"key":"72276_CR53","doi-asserted-by":"crossref","unstructured":"Bredefeld, C. et al. Guidance for the diagnosis and treatment of hypolipidemia disorders. J. Clin. Lipidol. 16, 797\u2013812 (2022).","DOI":"10.1016\/j.jacl.2022.08.009"},{"key":"72276_CR54","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s13105-014-0336-1","volume":"70","author":"P Quintero","year":"2014","unstructured":"Quintero, P. et al. Bile acid supplementation improves established liver steatosis in obese mice independently of glucagon-like peptide-1 secretion. J. Physiol. Biochem. 70, 667\u2013674 (2014).","journal-title":"J. Physiol. Biochem."},{"key":"72276_CR55","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/j.2040-4603.2013.tb00517.x","volume":"3","author":"JY Chiang","year":"2013","unstructured":"Chiang, J. Y. Bile acid metabolism and signaling. Compr. Physiol. 3, 1191\u20131212 (2013).","journal-title":"Compr. Physiol."},{"key":"72276_CR56","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1053\/j.gastro.2016.12.037","volume":"152","author":"JF de Boer","year":"2017","unstructured":"de Boer, J. F. et al. Intestinal farnesoid X receptor controls transintestinal cholesterol excretion in mice. Gastroenterology 152, 1126\u20131138.e1126 (2017).","journal-title":"Gastroenterology"},{"key":"72276_CR57","doi-asserted-by":"publisher","first-page":"70","DOI":"10.14797\/mdcj-15-1-70","volume":"15","author":"A Grefhorst","year":"2019","unstructured":"Grefhorst, A., Verkade, H. J. & Groen, A. K. The TICE pathway: mechanisms and lipid-lowering therapies. Methodist Debakey Cardiovasc J. 15, 70\u201376 (2019).","journal-title":"Methodist Debakey Cardiovasc J."},{"key":"72276_CR58","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1172\/JCI0216001","volume":"110","author":"L Yu","year":"2002","unstructured":"Yu, L. et al. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J. Clin. Investig. 110, 671\u2013680 (2002).","journal-title":"J. Clin. Investig."},{"key":"72276_CR59","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1194\/jlr.M054544","volume":"56","author":"J Wang","year":"2015","unstructured":"Wang, J. et al. Relative roles of ABCG5\/ABCG8 in liver and intestine. J. Lipid Res. 56, 319\u2013330 (2015).","journal-title":"J. Lipid Res."},{"key":"72276_CR60","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1093\/nar\/gkad067","volume":"51","author":"M Egli","year":"2023","unstructured":"Egli, M. & Manoharan, M. Chemistry, structure and function of approved oligonucleotide therapeutics. Nucleic Acids Res. 51, 2529\u20132573 (2023).","journal-title":"Nucleic Acids Res."},{"key":"72276_CR61","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41573-024-00912-9","volume":"23","author":"Q Tang","year":"2024","unstructured":"Tang, Q. & Khvorova, A. RNAi-based drug design: considerations and future directions. Nat. Rev. Drug Discov. 23, 341\u2013364 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"72276_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29473-9","volume":"8","author":"QN Wilson","year":"2018","unstructured":"Wilson, Q. N. et al. Greater microbial translocation and vulnerability to metabolic disease in healthy aged female monkeys. Sci. Rep. 8, 11373 (2018).","journal-title":"Sci. Rep."},{"key":"72276_CR63","first-page":"448","volume":"52","author":"MJ Jorgensen","year":"2013","unstructured":"Jorgensen, M. J., Aycock, S. T., Clarkson, T. B. & Kaplan, J. R. Effects of a Western-type diet on plasma lipids and other cardiometabolic risk factors in African green monkeys (Chlorocebus aethiops sabaeus). J. Am. Assoc. Lab Anim. Sci. 52, 448\u2013453 (2013).","journal-title":"J. Am. Assoc. Lab Anim. Sci."},{"key":"72276_CR64","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1194\/jlr.D300026-JLR200","volume":"45","author":"H Athar","year":"2004","unstructured":"Athar, H., Iqbal, J., Jiang, X. C. & Hussain, M. M. A simple, rapid, and sensitive fluorescence assay for microsomal triglyceride transfer protein. J. Lipid Res. 45, 764\u2013772 (2004).","journal-title":"J. Lipid Res."},{"key":"72276_CR65","doi-asserted-by":"publisher","first-page":"100086","DOI":"10.1016\/j.xpro.2020.100086","volume":"1","author":"M Charni-Natan","year":"2020","unstructured":"Charni-Natan, M. & Goldstein, I. Protocol for primary mouse hepatocyte isolation. STAR Protoc. 1, 100086 (2020).","journal-title":"STAR Protoc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72276-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72276-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72276-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:03:22Z","timestamp":1782777802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72276-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["72276"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-72276-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5655"}}